|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| Choose application no.
|
|
| |
|
|
| Application no. and date | 16713833.8 (espacenet) (Federated) (European Patent Register), 20160325 | | Patent/reg. no. and date | DK/EP 3273957, 20190814 | | Publication date | 20180131 | | Priority no. and date | EP 15305437, 20150326 | | EP pub. no. and date |
EP 3273957 20180131 | | Effective date | | | Applicant/owner | Medday Pharmaceuticals, 24/26 rue de la Pépinière
75008 Paris, FR | | Applicant ref. no. | 1502231 | | Inventor | SEDEL, Frédéric, c/o Medday Pharmaceuticals
24/26 rue de la Pépinière
7508 Paris, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4188 (2006.01) , A61P 25/28 (2006.01) | | Title | BIOTIN TIL BEHANDLING AF DEMYELINISERENDE NEUROPATIER | | Int. application no. | EP2016056696 | | Int. publication no. | WO2016151132 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
